Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Masked Evaluation of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate for the Treatment of Inflammation Following Cataract Surgery
Conditions
Locations
2
United States
Cincinnati Eye Institute
Edgewood, Kentucky, United States
Associated Eye Care
Stillwater, Minnesota, United States
Start Date
May 1, 2010
Primary Completion Date
July 1, 2011
Completion Date
November 1, 2011
Last Updated
June 29, 2017
Lead Sponsor
Associated Eye Care, Minnesota
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions